| Original language | English |
|---|---|
| Journal | Annals of the Rheumatic Diseases |
| Volume | 76 |
| Issue number | Suppl 2 |
| Pages (from-to) | 174 |
| Number of pages | 1 |
| ISSN | 0003-4967 |
| Publication status | Published - 2017 |
Evaluation of the impact of baseline levels of MRI-detected inflammation on treatment response in early, seropositive, MTX-NAÏVE RA: data from the AVERT trial
H. Ahmad, J. Baker, Mikkel Østergaard, P. Emery, P. Durez, J. Ye, S. Banerjee, P. Conaghan